Correlation Between Teva Pharma and Y MAbs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Teva Pharma and Y MAbs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teva Pharma and Y MAbs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Teva Pharma Industries and Y mAbs Therapeutics, you can compare the effects of market volatilities on Teva Pharma and Y MAbs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teva Pharma with a short position of Y MAbs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teva Pharma and Y MAbs.

Diversification Opportunities for Teva Pharma and Y MAbs

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Teva and YMAB is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharma Industries and Y mAbs Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Y mAbs Therapeutics and Teva Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teva Pharma Industries are associated (or correlated) with Y MAbs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Y mAbs Therapeutics has no effect on the direction of Teva Pharma i.e., Teva Pharma and Y MAbs go up and down completely randomly.

Pair Corralation between Teva Pharma and Y MAbs

Given the investment horizon of 90 days Teva Pharma is expected to generate 1.94 times less return on investment than Y MAbs. But when comparing it to its historical volatility, Teva Pharma Industries is 2.35 times less risky than Y MAbs. It trades about 0.07 of its potential returns per unit of risk. Y mAbs Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  488.00  in Y mAbs Therapeutics on September 2, 2024 and sell it today you would earn a total of  704.00  from holding Y mAbs Therapeutics or generate 144.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Teva Pharma Industries  vs.  Y mAbs Therapeutics

 Performance 
       Timeline  
Teva Pharma Industries 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Teva Pharma Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Y mAbs Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Y mAbs Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Teva Pharma and Y MAbs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Teva Pharma and Y MAbs

The main advantage of trading using opposite Teva Pharma and Y MAbs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teva Pharma position performs unexpectedly, Y MAbs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Y MAbs will offset losses from the drop in Y MAbs' long position.
The idea behind Teva Pharma Industries and Y mAbs Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.